(Q50859800)

English

Meta-analysis of transcriptome reveals let-7b as an unfavorable prognostic biomarker and predicts molecular and clinical subclasses in high-grade serous ovarian carcinoma.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/23825028

0 references

Meta-analysis of transcriptome reveals let-7b as an unfavorable prognostic biomarker and predicts molecular and clinical subclasses in high-grade serous ovarian carcinoma. (English)

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/23825028

0 references

0 references

0 references

author name string

Zhiqun Tang

1

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/23825028

Ghim Siong Ow

2

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/23825028

Jean Paul Thiery

3

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/23825028

Anna V Ivshina

4

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/23825028

Vladimir A Kuznetsov

5

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/23825028

language of work or name

0 references

publication date

7 August 2013

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/23825028

International Journal of Cancer

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/23825028

134

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/23825028

2

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/23825028

306-318

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/23825028

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

Modeling high-grade serous ovarian carcinogenesis from the fallopian tube

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

High-grade serous ovarian cancer arises from fallopian tube in a mouse model

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

New insights into the pathogenesis of serous ovarian cancer and its clinical impact

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

A microRNA survival signature (MiSS) for advanced ovarian cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

MicroRNA expression profiles in serous ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

MicroRNA expression and identification of putative miRNA targets in ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

Genomic DNA copy-number alterations of the let-7 family in human cancers

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

Rethinking ovarian cancer: recommendations for improving outcomes

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

MicroRNA signatures in human cancers

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

Targeting glioma stem cells by functional inhibition of a prosurvival oncomiR-138 in malignant gliomas

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

Identification of novel genes coding for small expressed RNAs

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

Roles for microRNAs in the regulation of cell adhesion molecules

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

Analysis of deep sequencing microRNA expression profile from human embryonic stem cells derived mesenchymal stem cells reveals possible role of let-7 microRNA family in downstream targeting of hepatic nuclear factor 4 alpha

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

Integrated genomic analyses of ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

Survival-related profile, pathways, and transcription factors in ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

Interobserver variability in the interpretation of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

Adjusting batch effects in microarray expression data using empirical Bayes methods

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

Data-driven approach to predict survival of cancer patients: estimation of microarray genes' prediction significance by Cox proportional hazard regression model

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

REporting recommendations for tumour MARKer prognostic studies (REMARK)

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

MIRUMIR: an online tool to test microRNAs as biomarkers to predict survival in cancer using multiple clinical data sets

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

MicroRNA miR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

miR-22 represses cancer progression by inducing cellular senescence

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

Autocrine activation of PDGFRalpha promotes the progression of ovarian cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

Differential gene expression in tamoxifen-resistant breast cancer cells revealed by a new analytical model of RNA-Seq data

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

Interference of Frizzled 1 (FZD1) reverses multidrug resistance in breast cancer cells through the Wnt/β-catenin pathway

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

HGF/MET signaling in ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

Identification of uPAR-positive chemoresistant cells in small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

Molecular profiling of platinum resistant ovarian cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

Efficacy of a replication-selective adenovirus against ovarian carcinomatosis is dependent on tumor burden, viral replication and p53 status

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28371

21 January 2018

Identifiers

10.1002/IJC.28371

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/23825028

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/23825028

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50859800&oldid=1237365885"